Cerebral blood flow and metabolism in late-life depression and dementia

Journal of Geriatric Psychiatry and Neurology

Volumn 12, Issue 3, 1999, Pages 118-127

  Nobler, Mitchell S ^a,b   Pelton, Gregory H ^a,b   Sackeim, Harold A ^a,b  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b New York State Psychiatric Institute ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; FLUORODEOXYGLUCOSE F 18; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; LORAZEPAM; NORTRIPTYLINE; PSYCHOTROPIC AGENT; SERTRALINE; XENON 133;

AGING; ALZHEIMER DISEASE; ARTICLE; BRAIN BLOOD FLOW; BRAIN METABOLISM; CLINICAL TRIAL; DEMENTIA; DEPRESSION; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DISEASE SEVERITY; ELECTROCONVULSIVE THERAPY; HUMAN; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PARIETAL LOBE; POSITRON EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TEMPORAL CORTEX; TOPOGRAPHY;

EID: 0033395819     PISSN: 08919887     EISSN: None     Source Type: Journal    
DOI: 10.1177/089198879901200305     Document Type: Article

References (111)

1. Kuchinsky W. Coupling of blood flow and metabolism in the brain. In: Phillis JW, ed. The regulation of cerebral blood flow. Boca Raton, FL: CRC Press, 1993:269-280.
2. Dunn RT, Willis M, Kimbrell TA, et al. Comparison of cerebral metabolism and blood flow in affective disorders. Biol Psychiatry 1999; 45:130S.
3. Sackeim HA, Lisanby SH, Nobler MS, et al. MRI hyperintensities in major depression: the meaning of encephalomalacia. In: Andrade C, ed. Progress in psychiatry. New York: Oxford University Press, in press.
4. Roland PE. Brain activation. New York: Wiley, 1993.
5. Grossman H, Harris G, Jacobson S, Folstein M. The normal elderly. In: Ames D, Chui E, eds. Neuroimaging and the psychiatry of late life. Cambridge, UK: Cambridge University Press, 1997:77-99.
6. Horwitz B, Duara R, Rapoport S. Age differences in intercorrelations between regional cerebral metabolic rates for glucose. Ann Neurol 1986; 19:60-67.
7. Martin AJ, Friston KJ, Colebatch JG, Frackowiak RS. Decreases in regional cerebral blood flow with normal aging. J Cereb Blood Flow Metab 1991; 11:684-689.
8. Petit-Taboue MC, Landeau B, Desson JF, et al. Effects of healthy aging on the regional cerebral metabolic rate of glucose assessed with statistical parametric mapping. Neuroimage 1998; 7:176-184.
9. Moeller JR, Ishikawa T, Dhawan V, et al. The metabolic topography of normal aging. J Cereb Blood Flow Metab 1996; 16:385-398.
10. Moeller J, Strother S, Sidtis J, et al. Scaled subprofile model: a statistical approach to the analysis of functional patterns in positron emission tomographic data. J Cereb Blood Flow Metab 1987; 7:649-658.
11. Sackeim HA, Prohovnik I. Brain imaging studies in depressive disorders. In: Mann JJ, Kupfer D, eds. Biology of depressive disorders. New York: Plenum, 1993:205-258.
12. Soares JC, Mann JJ. The functional neuroanatomy of mood disorders. J Psychiatr Res 1997; 31:393-432.
13. Drevets WC. Functional neuroimaging studies of depression: the anatomy of melancholia. Annu Rev Med 1998; 49:341-361.
14. Drevets WC, Videen TO, Price JL, et al. A functional anatomical study of unipolar depression. J Neurosci 1992; 12:3628-3641.
15. Biver F, Goldman S, Delvenne SV, et al. Frontal and parietal metabolic disturbances in unipolar depression. Biol Psychiatry 1994; 36:381-388.
16. Upadhyaya AK, Abou-Saleh MT, Wilson K, et al. A study of depression in old age using single-photon emission computerised tomography. Br J Psychiatry 1990; 157:76-81.
17. Curran SM, Murray CM, Van Beck M, et al. A single photon emission computerised tomography study of regional brain function in elderly patients with major depression and with Alzheimer-type dementia. Br J Psychiatry 1993; 163:155-165.
18. Bench CJ, Friston KJ, Brown RG, et al. Regional cerebral blood flow in depression measured by positron emission tomography: the relationship with clinical dimensions. Psychol Med 1993; 23:579-590.
19. Lesser IM, Mena I, Boone KB, et al. Reduction of cerebral blood flow in older depressed patients. Arch Gen Psychiatry 1994; 51:677-686.
20. Awata S, Ito H, Konno M, et al. Regional cerebral blood flow abnormalities in late-life depression: relation to refractoriness and chronification. Psychiatr Clin Neurosci 1998; 52:97-105.
21. Ebmeier KP, Glabus MF, Prentice N, et al. A voxel-based analysis of cerebral perfusion in dementia and depression of old age. Neuroimage 1998; 7:199-208.
22. Kumar A, Newberg A, Alavi A, et al. Regional cerebral glucose metabolism in late-life depression and Alzheimer disease: a preliminary positron emission tomography study. Proc Natl Acad Sci U S A 1993; 90:7019-7023.
23. Sackeim HA, Prohovnik I, Moeller JR, et al. Regional cerebral blood flow in mood disorders. I. Comparison of major depressives and normal controls at rest. Arch Gen Psychiatry 1990; 47:60-70.
24. Sackeim HA, Prohovnik I, Moeller JR, et al. Regional cerebral blood flow in mood disorders: II. Comparison of major depression and Alzheimer's disease. J Nucl Med 1993; 34:1090-1101.
25. Rubin E, Sackeim HA, Prohovnik I, et al. Regional cerebral blood flow in mood disorders: IV. Comparison of mania and depression. Psychiatr Res Neuroimaging 1995; 61:1-10.
26. Nobler MS, Roose SP, Prohovnik I, et al. Regional cerebral blood flow in mood disorders: V. Effects of antidepressant medication in late-life depression. Submitted for publication.
27. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967; 6:278-296.
28. Woods RP, Mazziotta JC, Cherry SR. MRI-PET registration with automated algorithm. J Comput Assist Tomogr 1993; 17:536-546.
29. Preskorn SH, Raichle ME, Hartman BK. Antidepressants alter cerebrovascular permeability and metabolic rate in primates. Science 1982; 217:250-252.
30. Gerber JC, Choki J, Brunswick DJ, et al. The effects of antidepressant drugs on regional cerebral glucose utilization in the rat. Brain Res 1983; 269:319-325.
31. Caldecott-Hazard S, Mazziotta J, Phelps M. Cerebral correlates of depressed behavior in rats, visualized using 14C-2-deoxyglucose autoradiography. J Neurosci 1988; 8:1951-1961.
32. Freo U, Pietrini P, Dam M, et al. The tricyclic antidepressant clomipramine dose-dependently reduces regional cerebral metabolic rates for glucose in awake rats. Psychopharmacology 1993; 113:53-59.
33. Reischies FM, Hedde JP, Drochner R. Clinical correlates of cerebral blood flow in depression. Psychiatry Res 1989; 29:323-326.
34. Hurwitz TA, Clark C, Murphy E, et al. Regional cerebral glucose metabolism in major depressive disorder. Can J Psychiatry 1990; 35:684-688.
35. Martinot JL, Hardy P, Feline A, et al. Left prefrontal glucose hypometabolism in the depressed state: a confirmation. Am J Psychiatry 1990; 147:1313-1317.
36. Goodwin GM, Austin MP, Dougall N, et al. State changes in brain activity shown by the uptake of 99mTc-exametazime with single photon emission tomography in major depression before and after treatment. J Affect Disord 1993; 29:243-253.
37. Bench CJ, Frackowiak RS, Dolan RJ. Changes in regional cerebral blood flow on recovery from depression. Psychol Med 1995; 25:247-261.
38. Passero S, Nardini M, Battistini N. Regional cerebral blood flow changes following chronic administration of antidepressant drugs. Prog Neuropsychopharmacol Biol Psychiatry 1995; 19:627-636.
39. Buchsbaum M, Wu J, Siegel B, et al. Effect of sertraline on regional metabolic rate in patients with affective disorder. Biol Psychiatry 1997; 41:15-22.
40. Rubin E, Sackeim HA, Nobler MS, et al. Brain imaging studies of antidepressant treatments. Psychiatr Ann 1994; 24:653-658.
41. Bonne O, Krausz Y, Shapira B, et al. Increased cerebral blood flow in depressed patients responding to electroconvulsive therapy. J Nucl Med 1996; 37:1075-1080.
42. Silfverskiöld P, Gustafson L, Risberg J, et al. Acute and late effects of electroconvulsive therapy: clinical outcome, regional cerebral blood flow, and electroencephalogram. Ann N Y Acad Sci 1986; 462:236-248.
43. Rosenberg R, Vostrup S, Andersen A, et al. Effect of ECT on cerebral blood flow in melancholia assessed with SPECT. Convuls Ther 1988; 4:62-73.
44. Volkow ND, Bellar S, Mullani N, et al. Effects of electroconvulsive therapy on brain glucose metabolism: a preliminary study. Convuls Ther 1988; 4:199-205.
45. Nobler MS, Sackeim HA, Prohovnik I, et al. Regional cerebral blood flow in mood disorders: III. Effects of treatment and clinical response in depression and mania. Arch Gen Psychiatry 1994; 51:884-897.
46. Nobler MS, Sackeim HA. Mechanisms of action of electroconvulsive therapy: functional brain imaging studies. Psychiatr Ann 1998; 28:23-29.
47. Berg L, Smith DS, Morris JC. Mild senile dementia of the Alzheimer's type. 3. Longitudinal and cross-sectional assessment. Ann Neurol 1990; 28:648-652.
48. Kukull WA, Larson EB, Reifler BV, et al. The validity of 3 clinical diagnostic criteria for Alzheimer's disease. Neurology 1990; 40:1364-1369.
49. Tierney MC, Fisher RH, Lewis AJ, et al. The NINCDS-ADRDA Work Group criteria for the clinical diagnosis of probable Alzheimer's disease: a clinicopathologic study of 57 cases. Neurology 1988; 38:359-364.
50. Kumar A, Schapiro MB, Haxby JV, et al. Cerebral metabolic and cognitive studies in dementia with frontal-lobe behavioral features. J Psychiatr Res 1990; 24:97-109.
51. Gur RC, Reivich M. Cognitive task effects on hemispheric blood flow in humans: evidence for individual differences in hemispheric activation. Brain Lang 1980; 9:78-92.
52. Mesulam MM. Dementia: its definition, differential diagnosis, and subtypes. JAMA 1985; 253:2559-2561.
53. Goldman-Rakic PS. Circuitry of the frontal association cortex and its relevance to dementia. Arch Gerontol Geriatr 1987; 6:299-309.
54. Nordberg A. Application of PET in dementia disorders. Acta Neurol Scand Suppl 1996; 168:71-76.
55. Tohgi H, Chiba K, Sasaki K, et al. Cerebral perfusion patterns in vascular dementia of Binswanger type compared with senile dementia of Alzheimer's type: a SPECT study. J Neurol 1991; 238:365-370.
56. Motomura N, Seo T. Lateral hemispheric asymmetries in senile dementia of Alzheimer's type (SDAT) assessed by I-123 IMP SPECT imaging: a preliminary report. Int J Neurosci 1992; 63:1-3.
57. Altrocchi PH, Brin M, Ferguson JH, et al. Assessment of brain SPECT - Report of Therapeutics and Technology-Assessment Subcommittee of the American Academy of Neurology. Neurology 1996; 46:278-285.
58. O'Brien JT, Eagger S, Syed GM, et al. A study of regional blood flow and cognitive performance in Alzheimer's disease. J Neurol Neurosurg Psychiatry 1992; 55:1182-1187.
59. Read SL, Miller BL, Mena I, et al. SPECT in dementia: clinical and pathological correlation. J Am Geriatr Soc 1995; 43:1243-1247.
60. Messa C, Perani D, Lucignani G. High-resolution technetium-99m-HMPAO SPECT in patients with probable Alzheimer's disease: comparison with fluorine-18-FDG PET. J Nucl Med 1994; 35:210-216.
61. Villa G, Cappa A, Tavolozza M, et al. Neuropsychological tests and 99mTc-Hm PAO SPECT in the diagnosis of Alzheimer's dementia. J Neurol 1995; 242:359-366.
62. Claus JJ, Vanharskamp F, Breteler MMB, et al. The diagnostic value of SPECT with TC-99m HMPAO in Alzheimer's disease -a population based study. Neurology 1999; 44:454-461.
63. Scheltens P. Early diagnosis of dementia: neuroimaging. J Neurol 1999; 246:16-20.
64. Van Gool WA, Walstra GJ, Teunisse S, et al. Diagnosing Alzheimer's disease in elderly, mildly demented patients: the impact of routine single photon emission computed tomography. J Neurol 1995; 242:401-405.
65. Jobst KA, Barnetson LP, Shepstone BJ. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and APO E4 medial temporal lobe dementias. The Oxford Project to Investigate Memory and Aging. Int Psychogeriatr 1997; 9(Suppl 1):191-222, 247-252.
66. Holman BL, Devous MD Sr. Functional brain SPECT: the emergence of a powerful clinical method. J Nucl Med 1992; 33:1888-1904.
67. Ryding E. SPECT measures of brain function in dementia; a review. Acta Neurol Scand Suppl 1996; 168:54-58.
68. Waldemar G, Bruhn P, Kristensen M, et al. Heterogeneity of neocortical cerebral blood flow deficits in dementia of the Alzheimer's type: a 99mTC-d, 1-HMPAO SPECT study. J Neurol Neurosurg Psychiatry 1994; 57:285-295.
69. Liu RS, Lin KN, Wang SJ, et al. Cognition and 99Tcm-HMPAO SPECT in Parkinson's disease. Nucl Med Commun 1992; 13:744-748.
70. Grunwald F, Horn R, Rieker O, et al. HMPAO-SPECT in Alzheimer-type dementia and major depression with memory disorders. Nuklearmedizin 1993; 32:128-133.
71. Lee HK, Herrera J, Valance J, et al. Tc-99m HMPAO brain SPECT with memory activation in Alzheimer's disease. J Nucl Med 1993; 34(Suppl):116.
72. Johnson KA, Jones K, Holman BL, et al. Preclinical prediction of Alzheimer's disease using SPECT. Neurology 1998; 50:1563-1571.
73. McKeith IG, Bartholomew PH, Irvine EM, et al. Single photon emission computerized tomography in elderly patients with Alzheimer's disease and multi-infarct dementia. Regional uptake of technetium-labelled HMPAO related to clinical measurements. Br J Psychiatry 1993; 163:597-603.
74. Dierckx RA, Vandewoude M, Saerens J, et al. Sensitivity and specificity of 99Tcm-HMPAO single-headed SPECT in dementia. Nucl Med Commun 1993; 14:792-797.
75. Seidere M, Krappel W, Moser E, et al. Detection and quantification of chronic cerebrovascular disease: comparison of MR imaging, SPECT, and CT. Radiology 1989; 170:545-548.
76. Battistin L, Pizzolato G, Dam M, et al. Regional cerebral blood flow study with 99mTc-hexamethyl-propyleneamine oxime single photon emission computed tomography in Alzheimer's and multi-infarct dementia. Eur Neurol 1990; 30:296-301.
77. Timmons JH, Heironimus JD. Coexistence of Alzheimer's disease and multi-infarct dementia diagnosed by functional brain imaging with SPECT. Clin Nucl Med 1990; 15:266-267.
78. Weinstein HC, Haan J, van Royen EO, et al. SPECT in the diagnosis of ALzheimer's disease and multi-infarct dementia. Clin Neurol Neurosurg 1991; 93:39-43.
79. Kawabata K, Tachibana H, Sugita M. Cerebral blood flow and dementia in Parkinson's disease. J Geriatr Psychiatry Neurol 1991; 4:194-203.
80. Habert MO, Spampinato U, Mas JL, et al. A comparative technetium 99m hexamethylpropane amine oxime SPECT study in different types of dementia. Eur J Nucl Med 1991; 18:3-11.
81. Sawada H, Udaka F, Kameyama M, et al. SPECT findings in Parkinson's disease associated with dementia. J Neurosurg Psychiatry 1992; 55:960-963.
82. Wang SJ, Liu RS, Liu HC, et al. Technetium-99m hexamethylpropylene amine oxime single photon emission tomography of the brain in early Parkinson's disease: correlation with dementia and lateralization. Eur J Nucl Med 1993; 20:339-344.
83. Granado JM, Diaz F, Alday R. Evaluation of brain SPECT in the diagnosis and prognosis of the normal pressure hydrocephalus syndrome. Acta Neurochir Wien 1991; 112:88-91.
84. Waldemar G. Functional brain imaging with SPECT in normal aging and dementia. Methodological, pathophysiological, and diagnostic aspects. Cerebrovasc Brain Metab Rev 1995; 7:89-130.
85. Larsson A, Bergh AC, Bilting M. Regional cerebral blood flow in normal pressure hydrocephalus: diagnostic and prognostic aspects. Eur J Nucl Med 1994; 21:118-123.
86. Kamiya K, Yamashita N, Nagai H, Mizawa I. Investigation of normal pressure hydrocephalus by 123I-IMP SPECT. Neurol Med Chir (Tokyo) 1991: 31:503-507.
87. Dolan RJ, Bench CJ, Brown RG. Regional cerebral blood flow abnormalities in depressed patients with cognitive impairment. J Neurol Neurosurg Psychiatry 1992; 55:768-773.
88. Kumar A. Functional brain imaging in late-life depression and dementia. J Clin Psychiatry 1993; 54(Suppl):21-25.
89. Guze BH, Hoffman JM, Baxter LR Jr, et al. Functional brain imaging and Alzheimer's-type dementia. Alzheimer Dis Assoc Disord 1991; 5:215-230.
90. Powers WJ, Perlmutter JS, Videen TO, et al. Blinded clinical evaluation of positron emission tomography for diagnosis of probable Alzheimer's disease. Neurology 1992; 42:765-770.
91. Hoffman JM, Guze BH, Baxter LR, et al. (18F)-fluorodeoxyglucose (FDG) and positron emission tomography (PET) in aging and dementia. A decade of studies. Eur Neurol 1989; 29(Suppl 3):16-24.
92. Benson DF, Kuhl DE, Hawkins RA, et al. The fluorodeoxyglucose 18F scan in Alzheimer's disease and multiinfarct dementia. Arch Neurol 1983; 40:711-714.
93. Duara R, Grady C, Haxby J, et al. Positron emission tomography in Alzheimer's disease. Neurology 1986; 36:879-887.
94. McGeer PL, Kamo H, Harrop R, et al. Positron emission tomography in patients with clinical diagnosed Alzheimer's disease. Can Med Assoc J 1986; 134:597-607.
95. Mielke R, Kessler J, Szelies B, et al. Normal and pathological aging - findings of positron-emission-tomography. J Neural Transm 1998; 105:821-837.
96. Mielke R, Herholz K, Grond M, et al. Severity of vascular dementia is related to volume of metabolically impaired tissue. Arch Neurol 1992; 49:909-913.
97. Grady CL, Haxby JV, Horowitz B, et al. Longitudinal study of the early neuropsychological and cerebral metabolic changes in dementia of the Alzheimer's type. J Clin Exp Neuropsychol 1988; 10:576-596.
98. Mielke R, Kessler J, Szelies B, et al. Vascular dementia: perfusion and metabolic disturbances and effects of therapy. J Neural Transm Suppl 1996; 47:183-191.
99. Reid WG, Broe GA, Hely MA, et al. The neuropsychology of de novo patients with idiopathic Parkinson's disease: the effect of age of onset. Int J Neurosci 1989; 48:205-217.
100. Kuhl DE, Metter EJ, Riege WH. Patterns of local cerebral glucose utilization determined in Parkinson's disease by the 18F-fluorodeoxyglucose method. Ann Neurol 1984; 15:419-424.
101. Brooks DJ. Functional imaging techniques in the diagnosis of non-Alzheimer dementias. J Neural Transm Suppl 1996; 47:155-167.
102. Kuhl DE, Metter EJ, Benson DF, et al. Similarities of cerebral glucose metabolism in Alzheimer's and Parkinson's dementia. J Cereb Blood Flow Metab 1985; 5:S169-S170.
103. Otsuka M, Ichiya Y, Hosokawa S, et al. Striatal blood flow, glucose metabolism, and F-dopa uptake: difference in Parkinson's disease and atypical parkinsonisms. J Neurol Neurosurg Psychiatry 1991; 54:898-904.
104. Eidelberg D, Moeller JR, Dhawan V, et al. The metabolic topography of parkinsonism. J Cereb Blood Flow Metab 1991; 14:783-801.
105. Maher ER, Lees AJ. The clinical features and natural history of the Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology 1986; 36:1005-1008.
106. Blin J, Baron JC, Dubois P, et al. Positron emission tomography study in progressive supranuclear palsy. Arch Neurol 1990; 47:747-752.
107. Davis PC, Mirra SS, Alazraki N. The brain in older persons with and without dementia: findings on MR, PET, and SPECT images. Am J Radiol 1994; 162:1267-1278.
108. Kamo H, McGeer PL, Harrop R, et al. Positron emission tomography and history in Pick's disease. Neurology 1987; 37:439-445.
109. Alexander GE, Prohovnik I, Sackeim HA, et al. Cortical perfusion and gray matter weight in frontal lobe dementia. J Neuropsychiatry 1995; 7:188-196.
110. Fazekas F, Alavi A, Chawluk JB, et al. Comparison of CT, MR, and PET in Alzheimer's dementia and normal aging. J Nucl Med 1989; 30:1607-1615.
111. Tanna NK, Kohn MI, Horwich DN, et al. Analysis of brain cerebrospinal fluid volumes with MR imaging - impact on PET data correction for atrophy. 2. Aging and Alzheimer's disease. Radiology 1991; 178:123-130.